Leeward Investments LLC MA Has $8.41 Million Holdings in Humana Inc. $HUM

Leeward Investments LLC MA lifted its position in shares of Humana Inc. (NYSE:HUM) by 15.5% during the 4th quarter, Holdings Channel.com reports. The firm owned 32,821 shares of the insurance provider’s stock after purchasing an additional 4,416 shares during the quarter. Leeward Investments LLC MA’s holdings in Humana were worth $8,407,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Montag A & Associates Inc. grew its holdings in shares of Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC grew its holdings in shares of Humana by 54.4% during the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Rosenberg Matthew Hamilton grew its holdings in shares of Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares in the last quarter. Larson Financial Group LLC grew its holdings in shares of Humana by 114.1% during the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares in the last quarter. Finally, Fulcrum Asset Management LLP acquired a new stake in shares of Humana during the 3rd quarter worth approximately $42,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Insider Activity

In other news, insider Sanjay K. Shetty bought 810 shares of the company’s stock in a transaction that occurred on Monday, February 23rd. The stock was acquired at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the transaction, the insider directly owned 11,657 shares of the company’s stock, valued at $2,158,992.97. This trade represents a 7.47% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.20% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent research reports. Morgan Stanley lifted their price objective on Humana from $146.00 to $217.00 and gave the stock an “underweight” rating in a report on Friday. Raymond James Financial restated an “outperform” rating and set a $260.00 price target on shares of Humana in a research note on Friday, May 1st. Wolfe Research cut their price target on shares of Humana from $325.00 to $250.00 and set an “outperform” rating for the company in a research note on Monday, April 6th. JPMorgan Chase & Co. raised their price target on shares of Humana from $180.00 to $214.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. Finally, Cantor Fitzgerald raised their price target on shares of Humana from $201.00 to $264.00 in a research note on Thursday, April 30th. Seven investment analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, Humana presently has a consensus rating of “Hold” and a consensus price target of $249.91.

Humana Trading Up 1.2%

Shares of Humana stock opened at $304.95 on Friday. The stock has a market capitalization of $36.61 billion, a P/E ratio of 32.62, a price-to-earnings-growth ratio of 2.81 and a beta of 0.68. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. The company has a 50-day simple moving average of $205.16 and a 200 day simple moving average of $227.04. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $315.35.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same quarter last year, the company posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Research analysts expect that Humana Inc. will post 8.97 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana’s dividend payout ratio (DPR) is 37.86%.

Trending Headlines about Humana

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Zacks Research upgraded Humana from “strong sell” to “hold”, which may be helping sentiment around the stock. Tickerreport.com
• Positive Sentiment: One report highlighted a higher price target for Humana (HUM), suggesting some analysts still see upside despite recent volatility. Article
• Neutral Sentiment: Humana, CenterWell and USAA partnered with the VFW on a national day of service supporting veterans experiencing homelessness, a positive brand event but not a direct earnings driver. Article
• Negative Sentiment: Zacks Research cut near-term and FY2026/FY2027 earnings estimates in several updates, including FY2026 to $9.01 from $9.90 and FY2027 to $13.26 from $14.16, signaling softer profitability expectations. MarketBeat HUM page
• Negative Sentiment: The same research house also projected a large loss in Q4 2026 and reduced estimates for several 2027 quarters, reinforcing concerns about earnings pressure ahead. MarketBeat HUM page

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.